Class of Stock [Axis] Series C Preferred Stock [Member] Equity Components [Axis] Common Stock [Member] Preferred Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Measurement Frequency [Axis] Fair Value, Recurring [Member] Cash and Cash Equivalents [Axis] Money Market Funds [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Financial Instrument [Axis] US Government Agencies Debt Securities [Member] Sale of Stock [Axis] At The Market Offering [Member] Pre Funded Warrant [Member] Warrant [Member] Series F Warrants [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Series I Warrants [Member] PreFunded Warrants [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Securities Purchase Agreement [Member] Preferred Stock Blank Check [Member] Award Type [Axis] Restricted Stock [Member] Title and Position [Axis] Employees and Directors [Member] Restricted Stock Units (RSUs) [Member] Chief Executive Officer [Member] Share-Based Payment Arrangement, Option [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Series G Warrants [Member] Series J Warrants [Member] Series K Warrants [Member] Geographical [Axis] UNITED STATES GERMANY ITALY POLAND RUSSIAN FEDERATION Other Countries [Member] Customer [Axis] Customer A [Member] Concentration Risk Benchmark [Axis] Sales [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer B [Member] Customer C [Member] Customer D [Member] Statement of Income Location, Balance [Axis] Research and Development Expense [Member] Selling and Marketing Expense [Member] General and Administrative Expense [Member] Employees And Consultants [Member] Directors [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Entity Listing, Par Value Per Share Statement of Financial Position [Abstract] ASSETS CURRENT ASSETS: Cash and cash equivalents Marketable securities Accounts receivable: Trade, net Other Prepaid expenses Inventory TOTAL CURRENT ASSETS NON-CURRENT ASSETS:     Long term deposit Property, plant and equipment, net Operating lease right of use assets Fund in respect of employee rights upon retirement TOTAL NON-CURRENT ASSETS TOTAL ASSETS LIABILITIES AND EQUITY CURRENT LIABILITIES: Accounts payable and accruals: Trade Other TOTAL CURRENT LIABILITIES LONG-TERM LIABILITIES- Operating lease liabilities net of current maturities Liability for employees’ rights upon retirement and others TOTAL LONG-TERM LIABILITIES TOTAL LIABILITIES COMMITMENTS AND CONTINGENT LIABILITIES EQUITY: Common stock, par value $0.0001 per share; 150,000,000 shares authorized at September 30, 2025 and December 31, 2024; 41,919,141 and 26,611,033 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively Preferred C shares, par value $0.0001 per share; 1,172,000 shares authorized at September 30, 2025 and December 31, 2024; 1,718 shares issued and outstanding at September 30, 2025 and December 31 2024, respectively Additional paid-in capital Accumulated deficit Total equity Total liabilities and equity Statement [Table] Statement [Line Items] Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Income Statement [Abstract] REVENUES COST OF REVENUES GROSS PROFIT OPERATING EXPENSES: Research and development Selling and marketing General and administrative Total operating expenses LOSS FROM OPERATIONS FINANCIAL INCOME, net: NET LOSS NET LOSS PER SHARE - basic NET LOSS PER SHARE - diluted WEIGHTED AVERAGE NUMBER OF ORDINARY SHARES USED IN COMPUTING NET LOSS PER SHARE - basic WEIGHTED AVERAGE NUMBER OF ORDINARY SHARES USED IN COMPUTING NET LOSS PER SHARE - diluted Balance Balance, shares Net loss Exercise of pre-funded warrants Exercise of pre-funded warrants, shares Exercise of Warrants to pre-funded warrants and common stock, net of issuance costs Exercise of Warrants to pre-funded warrants and common stock, net of issuance costs, shares Issuance of common shares, Included at the market offering net of $1 issuance costs Issuance of common stock, included at the market offering net of issuance costs, shares Share-based compensation related to stock, restricted stock, restricted stock units and stock options award, net of forfeitures of shares Share-based compensation related to stock, restricted stock, restricted stock units and stock options award, net of forfeitures of shares, shares Issuance of common stock, included at the market offering and pre-funded warrants net of issuance costs Issuance of common stock, included at the market offering and pre-funded warrants net of issuance costs, shares Balance Balance, shares Statement of Stockholders' Equity [Abstract] Number of pre-funded warrants issued Pre-funded warrants and common stock Issuance of common stock Market offering costs Shares restricted stock award, forfeited Market offering costs Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments required to reconcile net loss to net cash used in operating activities: Depreciation Gain from sale of property, plant and equipment Changes in fair value of marketable securities, net of interest received Change in liability for employees’ rights upon retirement Other financial income Change in operating right of use asset and operating leasing liability Share-based compensation expenses Loss (gain) on amounts funded in respect of employee rights upon retirement, net Changes in operating asset and liability items: Decrease (increase) in prepaid expenses Decrease (increase) in trade receivables Decrease (increase) in other receivables Increase in inventory Increase in trade payables Increase in other payables Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Purchase of property, plant and equipment Proceeds from sale of property, plant and equipment Investments in marketable securities Proceeds from matured marketable securities Amounts funded in respect of employee rights upon retirement Net cash provided by investing activities CASH FLOWS FROM FINANCING ACTIVITIES:     Proceeds from exercise of warrants, net of $1,000 issuance costs Proceeds from issuance of shares and pre-funded warrants, net of $3,148 and $1 issuance costs, respectively Net cash provided by financing activities EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS INCREASE IN CASH AND CASH EQUIVALENTS BALANCE OF CASH AND CASH EQUIVALENTS AT BEGINNING OF THE PERIOD BALANCE OF CASH AND CASH EQUIVALENTS AT END OF THE PERIOD SUPPLEMENTAL NON-CASH INVESTING AND FINANCING ACTIVITIES: Acquisition of right-of-use assets by means of lease liabilities Non- cash purchase of property and equipment Proceeds from issuance cost of warrants Proceeds from issuance of shares, net of issuance costs Organization, Consolidation and Presentation of Financial Statements [Abstract] DESCRIPTION OF BUSINESS BASIS OF PRESENTATION Accounting Changes and Error Corrections [Abstract] RECENTLY ADOPTED AND ISSUED ACCOUNTING PRONOUNCEMENTS Fair Value Disclosures [Abstract] FAIR VALUE MEASUREMENTS Investments, Debt and Equity Securities [Abstract] MARKETABLE SECURITIES Equity [Abstract] EQUITY Related Party Transactions [Abstract] RELATED PARTIES TRANSACTIONS Earnings Per Share [Abstract] NET LOSS PER SHARE Lease Agreements LEASE AGREEMENTS Investments, All Other Investments [Abstract] FINANCIAL INSTRUMENTS Inventory Disclosure [Abstract] INVENTORY Payables and Accruals [Abstract] ACCOUNTS PAYABLE AND ACCRUALS - OTHER Revenue from Contract with Customer [Abstract] DISAGGREGATED REVENUE Segment Reporting [Abstract] SEGMENT INFORMATION Subsequent Events [Abstract] SUBSEQUENT EVENTS SCHEDULE OF FINANCIAL ASSETS SUBJECT TO FAIR VALUE MEASUREMENTS SCHEDULE OF CHANGES IN FAIR VALUE OF MARKETABLE SECURITIES SCHEDULE OF ISSUANCE OF WARRANTS TO PURCHASE COMMON STOCK SCHEDULE OF WEIGHTED AVERAGE NUMBER OF SHARES SCHEDULE OF INVENTORIES SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUALS - OTHER SCHEDULE OF REVENUES ATTRIBUTED TO GEOGRAPHIC AREAS SCHEDULE OF REVENUES ATTRIBUTED TO GEOGRAPHIC AREAS BY PRINCIPAL CUSTOMERS SCHEDULE OF SEGMENT REVENUE Fair Value, off-Balance-Sheet Risk [Table] Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items] Money market funds U.S. government bonds Cost of marketable securities Balance at beginning of the period Additions Maturity Interest received Changes in fair value during the period Balance at end of the period Stock, Class of Stock [Table] Class of Stock [Line Items] Number of underlying common stock Weighted average exercise price Expiration date Expiration date Preferred stock convertible shares issuable Preferred stock stated value Warrants to purchase common stock Number of warrants expired Exercise of Warrants Series I to common stock, shares Exercise of Warrants Series I to common stock, shares Warrants exercise Private placement offering shares Warrants exercise Issuance costs Proceed from issuance costs Vesting period Offering price per share Issuance cost Number of shares of stock issued Gross proceeds of commonStock Total fee Capital stock shares authorized Capital stock par value Common stock shares authorized Preferred stock shares authorized Shares granted Fair value of shares granted Share based compensation arrangement by share based payment award options grants in period Stock option exercise price Expected dividend rate Expected term Expected volatility, minimum Expected volatility, maximum Risk-free interest rate, percentage Fair value stock option price Related Party Transaction [Table] Related Party Transaction [Line Items] Related party transaction, amount Weighted average number of ordinary shares Weighted average Vested restricted stock units Weighted average Pre-funded Warrants Total Weighted average number of ordinary shares used in computing net loss per share - basic Total Weighted average number of ordinary shares used in computing net loss per share - diluted Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Diluted loss per share Unvested restricted stock Operating lease liability Finished goods Work in process Raw materials and supplies Total inventory  Employees and employee institutions Accrued vacation and recreation pay Accrued expenses Clinical trials accrual Current Operating lease liabilities Other Accounts Payable and Accruals - Other Disaggregation of Revenue [Table] Disaggregation of Revenue [Line Items] Revenues Sales Percentage Schedule of Segment Reporting Information, by Segment [Table] Cost of Revenues: Material and Labor Other cost of revenues Total Cost of Revenues Research and development (R&D) Payroll and Benefits Share based compensation Clinical trials Other R&D Total Research and development Selling and marketing (S&M) Other S&M Total Selling and marketing General and administrative (G&A) Other G&A Total General and administrative Financial Income, net; Segment net Loss Number of reportable segment Number of reportable segment Subsequent Event [Table] Subsequent Event [Line Items] Company granted restricted shares Shares to employees and consultants Number of shares vested remaining Value stock warrants exercised. Stock issued during period value stock warrants exercised and common stock. Stock issued during period shares stock warrants exercised and common stock. Share based compensation related to restricted stock, restricted stock units and stock options award, net of forfeitures. Shares stock warrants exercised. Share based compensation related to restricted stock, restricted stock units and stock options award, net of forfeitures, shares. Changes in fair value of marketable securities. Change in liability for employees rights upon retirement. Change in operating lease assets and liabilities. Loss gain on amounts funded in respect of employee rights upon retirement net Marketable securities. Amounts with drawn in respect of employee rights upon retiremen Noncash acquisition of right of use assets by means of lease liabilities. Schedule of Changes in Fair Value of Marketable Securities [Table Text Block] Changes in fair value marketable securities. At The Market Offering [Member] Pre Funded Warrant [Member] Series F Warrants [Member] Series G Warrants [Member] Series J Warrants [Member] Series K Warrants [Member] Class of warrant or righst date from which warrants or right exercisable. Series I Warrants [Member] PreFunded Warrants [Member] Capital stock par value. Preferred Stock Blank Check [Member] Employees and Directors [Member] Weighted average prefunded warrants. Clinical trial accrual current. Accrued operating lease liabilities current. Customer C [Member] Customer D [Member] Schedule of Revenue and Expenses Reporting Segments [Table Text Block] Clinical trials. Securities Purchase Agreement [Member] Employees And Consultants [Member] Directors [Member] Other Countries [Member] Customer A [Member] Customer B [Member] Stock issued during period value stock including at market offering and Pre funded warrants. Stock issued during period shares stock including at market offering and Pre funded warrants. Non cash purchase of property and equipment. Non cash amounts funded in respect of employee rights upon retirement. Warrants expired. Stock issued during period shares of common stock. Assets, Current Assets, Noncurrent Assets Accounts Payable, Other, Current Liabilities, Current Liabilities, Noncurrent Liabilities Equity, Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Shares, Outstanding StockIssuedDuringPeriodSharesOfCommonStock Gain (Loss) on Disposition of Property Plant Equipment ChangesInFairValueOfMarketableSecurities ChangeInLiabilityForEmployeesRightsUponRetirement Other Noncash Income (Expense) ChangeInRightOfUseAssetAndLeasingLiability LossGainOnAmountsFundedInRespectOfEmployeeRightsUponRetirementNet Increase (Decrease) in Prepaid Expense Increase (Decrease) in Accounts Receivable Increase (Decrease) in Other Receivables Increase (Decrease) in Inventories Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Payments to Acquire Property, Plant, and Equipment AmountsWithdrawnInRespectOfEmployeeRightsUponRetirementNet Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Proceeds from Sale and Maturity of Marketable Securities Proceeds from Interest Received Class of Warrant or Right, Date from which Warrants or Rights Exercisable Other Accrued Liabilities, Current Number of Operating Segments